Abstract
Background
To evaluate the effect of injections of benzyl alcohol (BA)-free triamcinolone acetonide (TA) solution (MTA-PF) and the supernatant vehicle of TA (STA) containing BA into the subretinal space of rabbit eyes.
Methods
Sixteen rabbits underwent vitrectomy and subretinal injection of 0.02 ml of either 40 mg/ml MTA-PF, 40 mg/ml STA, or balanced salt solution (BSS). The animals were examined 6, 12, and 24 hours and 14 days after the procedure by fundus examination and fluorescein angiography (FA), as well as histological studies by light and transmission electron microscopy. The histological injury was classified in four stages: (1) stage 1, photoreceptor outer segment injury, (2) stage 2, stage 1 + photoreceptor inner segment injury, (3) stage 3, stage 2 + outer nuclear layer damage, and (4) stage 4, stage 3 + retinal pigment epithelium (RPE) damage.
Results
FA showed no window defects in areas where MTA-PF, STA, or BSS have been injected. Histological examination revealed that subretinal BSS-injection resulted in stage 1 damage during entire follow-up. Subretinal injection of MTA-PF resulted in damage stage 2 at 24 h and 14 days after surgery. However, at the STA position, stage 3 damage was noted 24 h and 14 days postoperatively. No RPE or choroidal damage was observed.
Conclusions
The histological lesions induced by subretinal STA were more relevant than the damage induced by MTA-PF. The vehicle BA may be involved in these abnormalities. The data indicate that care must be taken when using TA during internal limiting membrane peeling in macular hole surgery, due to the possibility of unintentional subretinal migration and for retinal pharmacotherapy.
Similar content being viewed by others
References
Jonas JB, Kreissig I, Degenring R (2005) Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 24:587–611
Rodrigues EB, Meyer CH, Kroll P (2005) Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 243:291–293
Shah GK, Rosemblat BJ, Smith M (2004) Internal limiting membrane peeling using TA: histopathologic confirmation. Am J Ophthalmol 138:656–657
Karacorlu M, Ozdemir H, Arf Karacorlu S (2005) Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery? Graefes Arch Clin Exp Ophthalmol 243:754–757
Maia M, Haller JA, Pieramici DJ, Margalit E, de Juan E Jr, Farah ME, Lakhanpal RR, Au Eong KG, Guven D, Humayun MS (2004) Retinal pigment epithelium abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina 24:157–160
Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44:5293–5300
Avci R, Kaderli B (2006) Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 244:28–35
Ramezani A, Entezari M, Moradian S, Tabatabaei H, Kadkhodaei S (2006) Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 244:1601–1606
Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190–195
Kertes PJ, Coupland SG (2005) The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study. Can J Ophthalmol 40:573–584
Beeley NR, Rossi JV, Mello-Filho PA, Mahmoud MI, Fujii GY, de Juan E Jr, Varner SE (2005) Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant. J Biomed Mater Res A 73:437–444
Albini TH, Abd-El-Barr MM, Carvounis PE, Iyer MN, Lakhanpal RR, Pennesi ME, Chevez-Barrios P, Wu SM, Holz ER (2007) Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci 48:390–395
Dierks D, Lei B, Zhang K, Hainsworth DP (2005) Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina. Arch Ophthalmol 123:1563–1569
McGee DH, Dembinska O, Gruebbel MM (2005) Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits. Int J Toxicol 24:419–425
Kozak I, Cheng L, Mendez T, Davidson MC, Freeman WR (2006) Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina 26:811–817
Macky TA, Helmy D, El Shazly N (2007) Retinal toxicity of triamcinolone’s vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study. Graefes Arch Clin Exp Ophthalmol 245:817–824
Hernaez-Ortega MC, Soto-Pedre E (2004) A simple and rapid method for purification of TA suspension for intravitreal injection. Ophthalmic Surg Laser Imaging 35:350–351
Garcia-Arumi J, Boixadera A, Giralt J, Martinez-Castillo V, Gomez-Ulla F, Corcostegui B, Garcia-Arumi E (2005) Comparison of different techniques for purification of TA suspension for intravitreal use. Br J Ophthalmol 89:1112–1114
Penha F, Maia M, Farah ME, Príncipe AH, Freymüller E, Maia A, Magalhães Jr O, Smith RL (2007) Effects of subretinal injection of indocyanine green, trypan blue and glucose in rabbit eyes. Ophthalmology 114(5):899–908
Maia M, Penha F, Rodrigues EB, Príncipe A, Dib E, Meyer CH, Freymuller E, Moraes N, Farah ME (2007) Effects of subretinal injection of patent blue and trypan blue in rabbits. Curr Eye Res 32(4):309–317
Maia M, Kellner L, de Juan E Jr, Smith R, Farah ME, Margalit E, Lakhanpal RR, Grebe L, Au Eong KG, Humayun MS (2004) Effects of indocyanine green injection over the retinal surface and into the subretinal space in rabbits. Retina 24:80–91
Modarres M, Parvaresh MM, Peyman GA (1998) Accidental subretinal injection of triamcinolone acetonide. Ophthalmic Surg Lasers 29:935–938
Fukukita M, Sasoh M, Matsubara H, Furuta M, Okawa C, Ito Y, Wakitani Y, Uji Y (2007) Triamcinolone acetonide remaining on the fovea after successful macular hole closure. Retina 27:122–123
Van de Moere A, Sandhu SS, Kak R, Mitchell KW, Talks SJ (2005) Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology 112:1896–903
Felt-Baeyens O, Eperon S, Mora P, Limal D, Sagodira S, Breton P, Simonazzi B, Bossy-Nobs L, Guex-Crosier Y, Gurny R (2006) Biodegradable scleral implants as new triamcinolone acetonide delivery systems. Int J Pharm 322:6–12
Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y (2004) Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant. Invest Ophthalmol Vis Sci 45:238–244
Kim H, Csaky KG, Gravlin L, Yuan P, Lutz RJ, Bungay PM, Tansey G, DE Monasterio F, Potti GK, Grimes G, Robinson MR (2006) Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina 26:523–530
Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M (2007) Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 84:342–348
Yu SY, Damico FM, Viola F, D’Amico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 26:531–536
Zemel E, Loewenstein A, Lei B, Lazar M, Perlman I (1995) Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity. Invest Ophthalmol Vis Sci 36:1875–1884
Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU (2006) Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Exp Eye Res 83:584–592
Szurman P, Kaczmarek R, Jaissle GB, Grisanti S, Luke M, Spitzer MS, Heide PE, Bartz-Schmidt KU (2006) Influence of different purification techniques on triamcinolone yield and particle size spectrum. Graefes Arch Clin Exp Ophthalmol 245:698–696
Tu AH, Equi R, Arai SI, Sadda S, Varner S, Rao N, de Juan E Jr (2004) Subretinal delivery of triamcinolone in a laser-induced primate model of choroidal neovascularization: angiographic and histopathological study. Invest Ophthalmol Vis Sci 45:E-Abstract 5055
Kai W, Yanrong J, Xiaoxin L (2006) Vehicle of TA is associated with retinal toxicity and transient increase of lens density. Graefes Arch Clin Exp Ophthalmol 244:1152–1159
Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47: 722–728
Walter P, Luck C, Sickel W (1999) Antibiotics and light responses in superfused bovine retina. Cell Mol Neurobiol 19:87–92
Morrison VL, Koh HJ, Cheng L, Bessho K, Davidson MC, Freeman WR (2006) Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 26:339–344
Hetherington NJ, Dooley MJ (2000) Potential for patient harm from intrathecal administration of preserved solutions. Med J Aust 173:141–143
Shaikh S, Ho S, Engelmann LA, Klemann SW (2006) Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 90:233–236
Acknowledgment
We wish to acknowledge the contribution of ALCON Laboratories to this study
Author information
Authors and Affiliations
Corresponding author
Additional information
Proprietary interest: Acácio AS Lima Filho has proprietary interests in the Ophthalmos Laboratories, São Paulo, Brazil
Financial support: São Paulo Research Foundation (FAPESP)
Rights and permissions
About this article
Cite this article
Maia, M., Penha, F.M., Farah, M.E. et al. Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study. Graefes Arch Clin Exp Ophthalmol 246, 379–388 (2008). https://doi.org/10.1007/s00417-007-0718-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0718-y